LY2090314

LY2090314, an effective GSK-3α/β inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer.

Price Not Available 25 mg LY2090314 Supplier Page

Catalog Number	T1755
Research Area	Stem Cells\|\|\|PI3K/Akt/mTOR signaling
Molecular Formula	C28H25FN6O3
CAS#	603288-22-8
Purity	99.88%
SMILES	N1(C(=O)N2CCCCC2)Cc2cc(cc3c(C4=C(c5cnc6n5cccc6)C(=O)NC4=O)cn(CC1)c23)F
Size	25 mg
Supplier Page	https://www.targetmol.com/compound/LY2090314
Additional Information	https://www.targetmol.com/datasheet/T1755